Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « range »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
randomly < range < ranged  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 33.
[0-20] [0 - 20][0 - 33][20-32][20-40]
Ident.Authors (with country if any)Title
000008 (2010) P. Roll [Allemagne] ; A. Rubbert-Roth [Allemagne] ; H.-P. Tony [Allemagne]Tocilizumab
000012 (2005) Norihiro Nishimoto [Japon]Clinical studies in patients with Castleman’s disease, Crohn’s disease, and rheumatoid arthritis in Japan
000015 (2013) Jörg Kaufmann [Allemagne] ; Eugen Feist [Allemagne] ; Anne-Eve Roske [Allemagne] ; Wolfgang A. Schmidt [Allemagne]Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice
000039 (2011) Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon]Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders
000089 (2013) Alfredo Adán [Espagne] ; Marina Mesquida [Espagne] ; Victor Llorenç [Espagne] ; Gerard Espinosa [Espagne] ; Blanca Molins [Espagne] ; Maria V. Hernández [Espagne] ; Laura Pelegrín [Espagne]Tocilizumab treatment for refractory uveitis-related cystoid macular edema
000181 (2015) Yi Zhang [États-Unis] ; Xiaohui Wei [États-Unis] ; Gaurav Bajaj [États-Unis] ; Jeffrey S. Barrett [États-Unis] ; Bernd Meibohm [États-Unis] ; Amita Joshi [États-Unis] ; Manish Gupta [États-Unis]Challenges and considerations for development of therapeutic proteins in pediatric patients
000212 (2013) Pierre GangloffBiothérapie et odontologie
000223 (2010) J. Möller [Allemagne] ; H. J. Girschick [Allemagne] ; G. Hahn [Allemagne] ; F. Pessler [Allemagne]Kortikosteroid-induzierte spinale epidurale Lipomatose bei pädiatrischen Patienten
000297 (2011) A. Schwarting [Allemagne]Nierenbeteiligung beim systemischen Lupus erythematodes
000314 (2010) Ukihide Tateishi [Japon] ; Tomoyuki Imagawa [Japon] ; Noriko Kanezawa [Japon] ; Tetsuhiko Okabe [Japon] ; Kazuya Shizukuishi [Japon] ; Tomio Inoue [Japon] ; Shumpei Yokota [Japon]PET assessment of disease activity in children with juvenile idiopathic arthritis
000569 (2012) L. Nibali [Royaume-Uni] ; S. Fedele [Royaume-Uni] ; F. D Iuto [Royaume-Uni] ; N. Donos [Royaume-Uni]Interleukin‐6 in oral diseases: a review
000636 (2013) M. Bodro [Espagne, Australie] ; D. L. Paterson [Australie]Listeriosis in patients receiving biologic therapies
000A41 (2008) S. Elitok [Allemagne] ; R. Kettritz [Allemagne]Pathogenese und Diagnostik von AA-Amyloidosen
000A62 (2007) Katsuaki Kanbe [Japon] ; Kazuhiko Inoue [Japon] ; Yasuo Inoue [Japon] ; Yutaka Suzuki [Japon]Histological changes in bone marrow after treatment of infliximab for rheumatoid arthritis
000A69 (2011) Babasaheb Bandgar [Inde] ; Baliram Hote [Inde] ; Rahul Gangwal [Inde] ; Abhay Sangamwar [Inde]Synthesis, biological evaluation, and pharmacokinetic profiling of benzophenone derivatives as tumor necrosis factor-alpha and interleukin-6 inhibitors
000B23 (2012) Justin Gillespie [Royaume-Uni] ; Sinisa Savic [Royaume-Uni] ; Chi Wong [Royaume-Uni] ; Aiden Hempshall [Royaume-Uni] ; Martyn Inman [Royaume-Uni] ; Paul Emery [Royaume-Uni] ; Ronald Grigg [Royaume-Uni] ; Michael F. Mcdermott [Royaume-Uni]Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3–selective inhibitor reduces interleukin‐6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients
000B97 (2015) Zhenhua Xu [États-Unis] ; Hugh M. Davis [États-Unis] ; Honghui Zhou [États-Unis]Clinical impact of concomitant immunomodulators on biologic therapy: Pharmacokinetics, immunogenicity, efficacy and safety
000C71 (2011) G. Dückers [Allemagne] ; T. Niehues [Allemagne]Rheuma bei Kindern und Jugendlichen
000C75 (2011) Richard Charles John Campbell [Royaume-Uni, Niger] ; Michael Batley [Royaume-Uni] ; Anthony Hammond [Royaume-Uni] ; Fowzia Ibrahim [Royaume-Uni] ; Gabrielle Kingsley [Royaume-Uni] ; David L. Scott [Royaume-Uni]The impact of disease activity, pain, disability and treatments on fatigue in established rheumatoid arthritis
000C86 (2013) Goohyeon Hong [Corée du Sud] ; Hojoong Kim [Corée du Sud, États-Unis]Clinical characteristics and treatment outcomes of patients with relapsing polychondritis with airway involvement
000E23 (2013) M. Zen [Italie] ; M. Gatto [Italie] ; M. Domeneghetti [Italie] ; L. Palma [Italie] ; E. Borella [Italie] ; L. Iaccarino [Italie] ; L. Punzi [Italie] ; A. Doria [Italie]Clinical Guidelines and Definitions of Autoinflammatory Diseases: Contrasts and Comparisons with Autoimmunity—a Comprehensive Review

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "range" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "range" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    range
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021